Historical Valuation
enVVeno Medical Corp (NVNO) is now in the Fair zone, suggesting that its current forward PS ratio of 4.72 is considered Fairly compared with the five-year average of -3.41. The fair price of enVVeno Medical Corp (NVNO) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.34
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
enVVeno Medical Corp (NVNO) has a current Price-to-Book (P/B) ratio of 0.24. Compared to its 3-year average P/B ratio of 1.36 , the current P/B ratio is approximately -82.40% higher. Relative to its 5-year average P/B ratio of 1.37, the current P/B ratio is about -82.46% higher. enVVeno Medical Corp (NVNO) has a Forward Free Cash Flow (FCF) yield of approximately -243.64%. Compared to its 3-year average FCF yield of -48.08%, the current FCF yield is approximately 406.71% lower. Relative to its 5-year average FCF yield of -37.93% , the current FCF yield is about 542.33% lower.
P/B
Median3y
1.36
Median5y
1.37
FCF Yield
Median3y
-48.08
Median5y
-37.93
Competitors Valuation Multiple
AI Analysis for NVNO
The average P/S ratio for NVNO competitors is 4.78, providing a benchmark for relative valuation. enVVeno Medical Corp Corp (NVNO.O) exhibits a P/S ratio of 4.72, which is -1.34% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for NVNO
1Y
3Y
5Y
Market capitalization of NVNO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of NVNO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is NVNO currently overvalued or undervalued?
enVVeno Medical Corp (NVNO) is now in the Fair zone, suggesting that its current forward PS ratio of 4.72 is considered Fairly compared with the five-year average of -3.41. The fair price of enVVeno Medical Corp (NVNO) is between to according to relative valuation methord.
What is enVVeno Medical Corp (NVNO) fair value?
NVNO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of enVVeno Medical Corp (NVNO) is between to according to relative valuation methord.
How does NVNO's valuation metrics compare to the industry average?
The average P/S ratio for NVNO's competitors is 4.78, providing a benchmark for relative valuation. enVVeno Medical Corp Corp (NVNO) exhibits a P/S ratio of 4.72, which is -1.34% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for enVVeno Medical Corp (NVNO) as of Jan 09 2026?
As of Jan 09 2026, enVVeno Medical Corp (NVNO) has a P/B ratio of 0.24. This indicates that the market values NVNO at 0.24 times its book value.
What is the current FCF Yield for enVVeno Medical Corp (NVNO) as of Jan 09 2026?
As of Jan 09 2026, enVVeno Medical Corp (NVNO) has a FCF Yield of -243.64%. This means that for every dollar of enVVeno Medical Corp’s market capitalization, the company generates -243.64 cents in free cash flow.
What is the current Forward P/E ratio for enVVeno Medical Corp (NVNO) as of Jan 09 2026?
As of Jan 09 2026, enVVeno Medical Corp (NVNO) has a Forward P/E ratio of -0.32. This means the market is willing to pay $-0.32 for every dollar of enVVeno Medical Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for enVVeno Medical Corp (NVNO) as of Jan 09 2026?
As of Jan 09 2026, enVVeno Medical Corp (NVNO) has a Forward P/S ratio of 4.72. This means the market is valuing NVNO at $4.72 for every dollar of expected revenue over the next 12 months.